文献速递免疫规划卫生政策与健康促进

卡介苗(BCG)疫苗:全球需求与供应平衡评估

Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance.
PubMed 文献 · Vaccine · 2017-12-15

该分析通过文献综述、供应商访谈、短缺与缺货评估、历史采购数据及需求预测,对全球卡介苗供应与需求动态进行深入分析。2017年全球产能显著增加,供应足以满足预测的卡介苗需求并可能缓冲市场冲击,但供应集中、生产流程改进投资有限及需求缺乏弹性等风险依然存在。

要点

  • 2017年全球卡介苗产能显著增加,供应足以满足预测需求并可能缓冲市场冲击。
  • 供应集中、生产流程改进投资有限及需求缺乏弹性是主要剩余风险。
  • 建议在信息共享、产品注册与生产投资激励、疫苗管理三方面实施风险缓解干预。

核心结论

  • 2017年全球卡介苗供应足以满足预测需求并可能缓冲市场冲击,但供应集中、生产流程改进投资有限及需求缺乏弹性等风险依然存在。

研究设计与样本

  • 通过文献综述、供应商访谈、短缺与缺货评估、历史采购数据分析及需求预测,对全球卡介苗供应与需求动态进行深入分析。

主要发现

  • 2017年全球卡介苗产能显著增加,供应足以满足预测需求并可能缓冲市场冲击。
  • 缺货频率保持稳定,但2014-2015年缺货持续时间因生产问题而增加。
  • 风险主要源于供应集中、生产流程改进投资有限及需求缺乏弹性。

临床怎么用

  • 作者提出在三个领域实施风险缓解干预:加强全球卫生行动者、国家与供应商之间的信息共享;识别扩大产品注册和卡介苗生产流程投资的利益与激励;与各国合作加强疫苗管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Over the past decade, several countries across all regions, income groups and procurement methods have been unable to secure sufficient BCG vaccine supply. While the frequency of stock-outs has remained rather stable, duration increased in 2014-2015 due to manufacturing issues and attracted the attention of national, regional and global immunization stakeholders. This prompted an in-depth analysis of supply and demand dynamics aiming to characterize supply risks. This analysis is unique as it provides a global picture, where previous analyses have focused on a portion of the market procuring through UN entities. Through literature review, supplier interviews, appraisal of shortages, stock-outs and historical procurement data, and through demand forecasting, this analysis shows an important increase in global capacity in 2017: supply is sufficient to meet forecasted BCG vaccine demand and possibly buffer market shocks. Nevertheless, risks remain mainly due to supply concentration and limited investment in production process improvements, as well as inflexibility in demand. Identification of these market risks will allow implementation of risk-mitigating interventions in three areas: (1) enhancing information sharing between major global health actors, countries and suppliers, (2) identifying interests and incentives to expand product registration and investment in the BCG manufacturing process, and (3) working with countries for tighter vaccine management.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cernuschi T, Malvolti S, Nickels E, et al. Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance. Vaccine. 2017. PMID: 29254839. doi:10.1016/j.vaccine.2017.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。